About This Source - CGTN
This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.
Recent from CGTN:
CGTN published this video item, entitled “China approves Sinopharm and Sinovac jabs for emergency use for children aged 3 to 17” – below is their description.
The #Sinopharm and #Sinovac #vaccines have been approved by Chinese health authorities for conditional marketing. Following their authorization for adults, they have continued to carry out expanded clinical trials, and they have been proven safe for the 3 to 17 age group after careful evaluation and expert reviews. The results show that these vaccines have a strong capability to induce the production of antibodies.CGTN YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: China
7 Recent Items: China
In This Story: Sinopharm
China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.